COHERUS BIOSCIENCES I
0.8200
07-十一月-24 15:59:58
15 分钟延时
股票
+0.0962
+13.29%
今日范围
0.7610 - 0.9550
ISIN
N/A
来源
NASDAQ
-
CIMERLI® (ranibizumab-eqrn) Sales Exceed 100,000 Doses in First Year of Launch
04 10月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
Coherus Applauds Congressional Designation of September 30th as Rare Cancer Day
02 10月 2023 09:00:00 条件 Nasdaq GlobeNewswire
-
27 9月 2023 09:10:29 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
22 9月 2023 21:00:00 条件 Nasdaq GlobeNewswire
-
Coherus Completes Surface Oncology Acquisition
08 9月 2023 09:05:40 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences to Participate at Upcoming September Investor Conferences
01 9月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
22 8月 2023 17:35:22 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences Reports Second Quarter 2023 Financial Results and Business Highlights
02 8月 2023 16:01:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences to Report Second Quarter 2023 Financial Results on August 02, 2023
26 7月 2023 16:05:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
21 7月 2023 17:30:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences Appoints Dr. Michael Ryan to its Board of Directors
20 7月 2023 16:04:53 条件 Nasdaq GlobeNewswire
-
Coherus and Superior Biologics Announce National Distribution Agreement for YUSIMRY™
13 7月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
Coherus Launches YUSIMRY™, a Biosimilar of Humira®, at $995 per Carton in U.S.
03 7月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
Coherus BioSciences Announces New Employment Inducement Grants
26 6月 2023 21:08:00 条件 Nasdaq GlobeNewswire
-
Coherus to Acquire Surface Oncology
16 6月 2023 07:01:00 条件 Nasdaq GlobeNewswire
-
05 6月 2023 17:30:00 条件 Nasdaq GlobeNewswire
-
01 6月 2023 08:33:07 条件 Nasdaq GlobeNewswire
-
01 6月 2023 08:30:00 条件 Nasdaq GlobeNewswire
-
Coherus Announces U.S. Launch of UDENYCA® Autoinjector
22 5月 2023 08:30:00 条件 Nasdaq GlobeNewswire